Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Male breast cancer: genetics, epigenetics, and ethical aspects.

Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K, Falchetti M, Gulino M, Frati P, Ottini L.

Ann Oncol. 2013 Nov;24 Suppl 8:viii75-viii82. doi: 10.1093/annonc/mdt316. Review.

PMID:
24131976
2.

Different methylation and microRNA expression pattern in male and female familial breast cancer.

Pinto R, Pilato B, Ottini L, Lambo R, Simone G, Paradiso A, Tommasi S.

J Cell Physiol. 2013 Jun;228(6):1264-9. doi: 10.1002/jcp.24281.

PMID:
23160909
3.

Molecular profiling of male breast cancer - lost in translation?

Johansson I, Killander F, Linderholm B, Hedenfalk I.

Int J Biochem Cell Biol. 2014 Aug;53:526-35. doi: 10.1016/j.biocel.2014.05.007. Epub 2014 May 16. Review.

4.

Male breast cancer: a gender issue.

Nahleh Z, Girnius S.

Nat Clin Pract Oncol. 2006 Aug;3(8):428-37. Review.

PMID:
16894388
5.

Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy.

Silvestri V, Rizzolo P, Scarnò M, Chillemi G, Navazio AS, Valentini V, Zelli V, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M, Pensotti V, Peterlongo P, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D, Ottini L.

Eur J Cancer. 2015 Nov;51(16):2289-95. doi: 10.1016/j.ejca.2015.07.020. Epub 2015 Aug 3.

PMID:
26248686
6.

Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy.

Silvestri V, Rizzolo P, Falchetti M, Zanna I, Masala G, Bianchi S, Palli D, Ottini L.

Breast Cancer Res Treat. 2011 Apr;126(2):539-43. doi: 10.1007/s10549-010-1289-x. Epub 2010 Dec 17.

PMID:
21165771
7.

Male breast cancer--an andrological disease: risk factors and diagnosis.

Krause W.

Andrologia. 2004 Dec;36(6):346-54. Review.

PMID:
15541050
8.

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.

Ottini L, Rizzolo P, Zanna I, Falchetti M, Masala G, Ceccarelli K, Vezzosi V, Gulino A, Giannini G, Bianchi S, Sera F, Palli D.

Breast Cancer Res Treat. 2009 Aug;116(3):577-86. doi: 10.1007/s10549-008-0194-z. Epub 2008 Sep 26.

PMID:
18819001
9.

Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy.

Ottini L, Silvestri V, Saieva C, Rizzolo P, Zanna I, Falchetti M, Masala G, Navazio AS, Graziano V, Bianchi S, Manoukian S, Barile M, Peterlongo P, D'Amico C, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2013 Apr;138(3):861-8. doi: 10.1007/s10549-013-2459-4. Epub 2013 Mar 7.

PMID:
23468243
10.

Epigenetic biomarkers in prostate cancer: Current and future uses.

Chiam K, Ricciardelli C, Bianco-Miotto T.

Cancer Lett. 2014 Jan 28;342(2):248-56. doi: 10.1016/j.canlet.2012.02.011. Epub 2012 Mar 3. Review.

PMID:
22391123
11.

Male breast cancer.

Joseph A, Mokbel K.

Int J Fertil Womens Med. 2004 Sep-Oct;49(5):198-9. Review.

PMID:
15633473
13.

Epigenetics and microRNAs in preeclampsia.

Choudhury M, Friedman JE.

Clin Exp Hypertens. 2012;34(5):334-41. doi: 10.3109/10641963.2011.649931. Epub 2012 Apr 2.

14.

Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.

Ottini L, Rizzolo P, Zanna I, Silvestri V, Saieva C, Falchetti M, Masala G, Navazio AS, Capalbo C, Bianchi S, Manoukian S, Barile M, Peterlongo P, Caligo MA, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Cini G, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2014 Dec;148(3):623-8. doi: 10.1007/s10549-014-3193-2. Epub 2014 Nov 11.

PMID:
25385181
15.

The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment.

Basse C, Arock M.

Int J Cancer. 2015 Dec 15;137(12):2785-94. doi: 10.1002/ijc.29347. Epub 2014 Dec 1. Review.

16.

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.

Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M, Peterlongo P, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2012 Jul;134(1):411-8. doi: 10.1007/s10549-012-2062-0. Epub 2012 Apr 18.

PMID:
22527108
17.

The most common genes involved in epigenetics modifications among Iranian patients with breast cancer: A systematic review.

Iranshahi N, Zafari P, Yari KH, Alizadeh E.

Cell Mol Biol (Noisy-le-grand). 2016 Oct 31;62(12):116-122. doi: 10.14715/cmb/2016.62.12.20. Review.

PMID:
27894412
18.

The context and potential of epigenetics in oncology.

Lopez J, Percharde M, Coley HM, Webb A, Crook T.

Br J Cancer. 2009 Feb 24;100(4):571-7. doi: 10.1038/sj.bjc.6604930. Review.

19.

Male breast cancer: risk factors, diagnosis, and management (Review).

Johansen Taber KA, Morisy LR, Osbahr AJ 3rd, Dickinson BD.

Oncol Rep. 2010 Nov;24(5):1115-20. Review.

PMID:
20878100
20.

CHEK2 1100delC and male breast cancer in the Netherlands.

Wasielewski M, den Bakker MA, van den Ouweland A, Meijer-van Gelder ME, Portengen H, Klijn JG, Meijers-Heijboer H, Foekens JA, Schutte M.

Breast Cancer Res Treat. 2009 Jul;116(2):397-400. doi: 10.1007/s10549-008-0162-7. Epub 2008 Aug 31.

PMID:
18759107

Supplemental Content

Support Center